Center for Women's Cancer Access and Advocacy
Binaytara has implemented a comprehensive approach to enhance women’s cancer care access, focusing on cervical cancer screening, chemotherapy services, advocacy, and the establishment of a women’s cancer center. Through these multifaceted initiatives, Binaytara demonstrates a strong commitment to improving women’s cancer care access, particularly in underserved regions. By combining screening programs, treatment services, advocacy, and expert collaboration, Binaytara strives to reduce cancer disparities and enhance health outcome for women.
Our Initiatives
Learn about our projects to improve women's cancer outcomes
Early Detection
Cervical Cancer Screening Programs
Recognizing the critical need for early detection, Binaytara initiated cervical cancer screening programs in Janakpur, Nepal. These programs employ visual inspection with acetic acid (VIA), a cost-effective method suitable for low-resource settings.
Advocacy
Advocacy and Plans for a Women’s Cancer Center
Binaytara actively advocates for improved access to women’s cancer care through partnerships with local communities, government entities, and healthcare institutions. These efforts have led to an agreement with the Government of Nepal to develop a 200-bed cancer hospital in Janakpur, serving over six million people in Madhesh Province.
Treatment
Chemotherapy Services at the 25-Bed Hospital
In 2018, Binaytara established a 25-bed cancer hospital in Janakpur, Nepal, offering chemotherapy services to women diagnosed with cancer. The hospital provides treatment for various cancers, including breast, cervical and other gynecological cancers, ensuring that women receive timely and appropriate care. By delivering these services locally, Binaytara reduces the need for patients to travel long distances, thereby improving treatment adherence and outcomes.
Our Team
CWCAA is managed by leading oncologists and supported by Binaytara's Global Health and Health Disparities interns.
Tara Shah, RN
Chair
Elizabeth Lynn Meyering, MD
Member
WHERE DOES THIS BIO APPEAR?
Mark Pegram, MD
Member
Mark Pegram, MD, is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at the Stanford University School of Medicine. He currently serves as the Associate Director of Clinical Research at the Stanford Comprehensive Cancer Institute (SCCI). Dr. Pegram also serves as the Associate Dean for Clinical Research Quality at the Stanford University School of Medicine, and is the Medical Director of the Stanford Clinical Translational Research Unit – a unit specializing in first-in-human phase I clinical trials. Dr. Pegram is a longtime board member with Binaytara and he is the recipient of the Binaytara Eternal Service Award for his dedication to educating doctors, and improving the lives of cancer patients through his breakthrough research and clinical care.
Wendy Wang, MD, PhD
Member
Siddhartha Yadav, MBBS, MD
Member
News and Articles
Read our blogs and articles on Center for Women's Cancer Access and Advocacy.
The Hidden Connection: How HPV Awareness and Early Screening Can Prevent Cervical Cancer
2/27/2025
HPV causes most cervical cancers, but prevention is possible. Learn how awareness, vaccination, and screening can save lives.
The Ripple Effect Of Investing In Women’s Cancer Care: Empowering Economies, Families And Society
Mammogram Screening: Debunking 12 Common Myths That Every Woman Should Be Aware Of
